Adaptive and innate transforming growth factor β signaling impact herpes simplex virus 1 latency and reactivation

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 11448-11456

  Allen, Sariah J ^a   Mott, Kevin R ^a   Wechsler, Steven L ^b   Flavell, Richard A ^c   Town, Terrence ^d,e,f   Ghiasi, Homayon ^a  

^a Department of Surgery and Regenerative Medicine Institute ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CSMC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOLYSIS; EYE INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 1 INFECTION; INNATE IMMUNITY; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL; T LYMPHOCYTE; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; EYE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; MICE; MICE, TRANSGENIC; RODENT DISEASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRIGEMINAL GANGLION; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; MUS; MUS MUSCULUS;

EID: 80055112238     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00678-11     Document Type: Article

References (75)

1. Abendroth, A., et al. 2000. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J. Virol. 74:1900-1907.
2. Adler, H., et al. 1998. A role for transforming growth factor-beta1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type 1 infection. Blood 92:2581-2589.
3. Allen, S. J., et al. 2011. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J. Virol. 85:4184-4197.
4. Allen, S. J., K. R. Mott, A. V. Ljubimov, and H. Ghiasi. 2010. Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mice. Virology 399:11-22.
5. Allen, S. J., K. R. Mott, M. Zandian, and H. Ghiasi. 2010. Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in HSV-1 infected mice. J. Virol. 84:12315-12324.
6. Aubert, M., E. M. Krantz, and K. R. Jerome. 2006. Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyteinduced cytotoxicity. Viral Immunol. 19:391-408.
7. Aurelian, L. 2005. HSV-induced apoptosis in herpes encephalitis. Curr. Top. Microbiol. Immunol. 289:79-111.
8. Barber, D. L., et al. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687.
9. Brandt, C. R., and C. A. Salkowski. 1992. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest. Ophthalmol. Vis. Sci. 33:113-120.
10. Cebulla, C. M., et al. 2002. Human cytomegalovirus disrupts constitutive MHC class II expression. J. Immunol. 169:167-176.
11. Chemnitz, J. M., et al. 2007. RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma. Blood 110:3226-3233.
12. Day, C. L., et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354.
13. de Caestecker, M. 2004. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev. 15:1-11.
14. Dunker, N., and K. Krieglstein. 2000. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267:6982-6988.
15. Fernandez, M. A., et al. 2008. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 180:1556-1564.
16. Fraser, N. W., T. M. Block, and J. G. Spivack. 1992. The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology 191:1-8.
17. Galvan, V., and B. Roizman. 1998. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 95:3931-3936.
18. Geiser, A. G., et al. 1993. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc. Natl. Acad. Sci. U. S. A. 90:9944-9948.
19. Ghiasi, H., S. Bahri, A. B. Nesburn, and S. L. Wechsler. 1995. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1352-1360.
20. Ghiasi, H., S. Cai, A. B. Nesburn, and S. L. Wechsler. 1996. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Virology 224:330-333.
21. Ghiasi, H., S. Cai, G. Perng, A. B. Nesburn, and S. L. Wechsler. 1999. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring. Virus Res. 65:97-101.
22. Ghiasi, H., S. Cai, G. C. Perng, A. B. Nesburn, and S. L. Wechsler. 2000. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res. 45:33-45.
23. Ghiasi, H., et al. 1999. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease. J. Infect. Dis. 179: 1086-1093.
24. Ghiasi, H., G. Perng, A. B. Nesburn, and S. L. Wechsler. 1999. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microb. Pathog. 27:387-394.
25. Ghiasi, H., et al. 1997. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology 91:430-435.
26. Ghiasi, H., S. L. Wechsler, S. Cai, A. B. Nesburn, and F. M. Hofman. 1998. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology 95:352-359.
27. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171-181.
28. Hill, T. J. 1987. Ocular pathogenicity of herpes simplex virus. Curr. Eye Res. 6:1-7.
29. Jones, T. R., et al. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U. S. A. 93:11327-11333.
30. Kaartinen, V., et al. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:415-421.
31. Kagimoto, Y., et al. 2008. A regulatory role of interleukin 15 in wound healing and mucosal infection in mice. J. Leukoc. Biol. 83:165-172.
32. Kaufman, H. E., et al. 2005. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 46:241-247.
33. Koelle, D. M., and H. Ghiasi. 2005. Prospects for developing an effective vaccine against ocular herpes simplex virus infection. Curr. Eye Res. 30:929-942.
34. Kuklin, N. A., M. Daheshia, S. Chun, and B. T. Rouse. 1998. Immunomodulation by mucosal gene transfer using TGF-beta DNA. J. Clin. Invest. 102: 438-444.
35. Kulkarni, A. B., et al. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U. S. A. 90:770-774.
36. Laouar, Y., F. S. Sutterwala, L. Gorelik, and R. A. Flavell. 2005. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 6:600-607.
37. Laouar, Y., et al. 2008. TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 105:10865-10870.
38. Lee, Y. J., et al. 1997. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:2065-2075.
39. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24:99-146.
40. Liesegang, T. J. 1999. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18:127-143.
41. Liesegang, T. J. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13.
42. Lin, A., H. Xu, and W. Yan. 2007. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell. Mol. Immunol. 4:91-98.
43. Massague, J. 1990. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:597-641.
44. Mott, K. R., and H. Ghiasi. 2008. Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice. Clin. Vaccine Immunol. 15:1859-1867.
45. Mott, K. R., et al. 2007. The corneas of naive mice contain both CD4+ and CD8+ T cells. Mol. Vis. 13:1802-1812.
46. Mott, K. R., G. C. Perng, Y. Osorio, K. G. Kousoulas, and H. Ghiasi. 2007. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J. Virol. 81:12962-12972.
47. + dendritic cells are involved in enhancing HSV-1 latency. J. Virol. 82:9870-9879.
48. Mueller, S. N., and R. Ahmed. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 106:8623-8628.
49. Osorio, Y., and H. Ghiasi. 2003. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes. J. Virol. 77:5774-5783.
50. Panek, R. B., Y. J. Lee, and E. N. Benveniste. 1995. TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression. J. Immunol. 154:610-619.
51. - T cells. Int. Immunol. 16:1203-1213.
52. Perng, G. C., et al. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68:8045-8055.
53. Perng, G. C., et al. 2000. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287:1500-1503.
54. Posavad, C. M., and K. L. Rosenthal. 1992. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J. Virol. 66:6264-6272.
55. Proetzel, G., et al. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11:409-414.
56. Radosevich, T. J., T. Seregina, and C. J. Link. 2003. Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure. Hum. Gene Ther. 14:1765-1775.
57. Rock, D. L., et al. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:3820-3826.
58. Roizman, B., and A. E. Sears. 1987. An inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41:543-571.
59. Sanford, L. P., et al. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670.
60. Schwyzer, M., et al. 2002. Transduction of Vero cells and bovine monocytes with a herpes simplex virus-1 based amplicon carrying the gene for the bovine herpesvirus-1 Circ protein. Vet. Microbiol. 86:165-174.
61. Shvets, A., et al. 2009. Impaired negative regulation of homeostatically proliferating T cells. Blood 113:622-625.
62. Steiner, I. 1996. Human herpes viruses latent infection in the nervous system. Immunol. Rev. 152:157-173.
63. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
64. Trgovcich, J., D. Johnson, and B. Roizman. 2002. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1. J. Virol. 76:6974-6986.
65. Tumpey, T. M., et al. 1998. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J. Virol. 72:3705-3710.
66. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338-344.
67. Wahl, S. M. 2007. Transforming growth factor-beta: innately bipolar. Curr. Opin. Immunol. 19:55-62.
68. Wahl, S. M., J. Wen, and N. Moutsopoulos. 2006. TGF-beta: a mobile purveyor of immune privilege. Immunol. Rev. 213:213-227.
69. Wechsler, S. L., A. B. Nesburn, R. Watson, S. Slanina, and H. Ghiasi. 1988. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J. Gen. Virol. 69:3101-3106.
70. Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:4051-4058.
71. Wiertz, E. J., et al. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779.
72. Wilhelmus, K. R., et al. 1996. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Br. J. Ophthalmol. 80:969-972.
73. Wilson, S. E., L. Pedroza, R. Beuerman, and J. M. Hill. 1997. Herpes simplex virus type-1 infection of corneal epithelial cells induces apoptosis of the underlying keratocytes. Exp. Eye Res. 64:775-779.
74. Wuest, T., J. Farber, A. Luster, and D. J. Carr. 2006. CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol. 243:83-89.
75. Zuniga, J. E., et al. 2005. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. J. Mol. Biol. 354:1052-1068.